Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Astellas Pharma Inc (OTC Pink - Current Information:ALPMF.PK)

13.20
Delayed Data
As of Oct 19
 0.00 / 0.00%
Today’s Change
11.89
Today|||52-Week Range
15.25
-7.96%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$27.3B

Company Description

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Contact Information

Astellas Pharma, Inc.
2-5-1 Nihonbashi-Honcho
Tokyo Tokyo 103-8411
P:(133) 244-3000
Investor Relations:
(133) 244-3271

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Yoshihiko HatanakaPresident, CEO & Representative Director
Yasumasa MasudaChief Financial Officer
Mitsunori MatsudaSenior Executive Officer & President-Technology
Yoshiro MiyokawaRepresentative Director & Executive Vice President
Linda FriedmanExecutive Vice President & General Counsel